Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyarginine Treated Vein Grafts for CABG
NCT01313533Phase 2Unknown
- Sponsor
- St. Luke's Hospital
- Start
- Mar 2015
- Primary completion
- Dec 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nona-l-arginine in atherosclerosis, sponsored by St. Luke's Hospital. Status: unknown.
02
Drugs
nona-l-arginine
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT01313533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313533.